Gastric Antral Vascular Ectasia Clinical Trial
Official title:
Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial
The investigators goal is to compare the standard argon plasma coagulation (APC) treatment with endoscopic band ligation (EBL) in patients with Gastric Antral Vascular Ectasia.
Gastric antral vascular ectasia (GAVE) is a vascular structural malformation in the stomach
that can lead to active or chronic intermittent gastrointestinal bleeding or chronic
iron-deficiency anemia.
The current standard endoscopic treatment is with APC. There have been multiple reports and
case series in the literature about successful treatment with EBL for GAVE, even in cases
where APC was unsuccessful for treatment of GAVE. Our goal is to compare the standard APC
treatment with EBL in patients with Gastric Antral Vascular Ectasia.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00964496 -
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
|
Phase 2 | |
| Completed |
NCT04388150 -
Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis
|
||
| Recruiting |
NCT06306963 -
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
|
||
| Recruiting |
NCT05690750 -
Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.
|
||
| Recruiting |
NCT03525366 -
Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)
|